Alfadil Haroon/Photo: researchgate.net
Jun 13, 2026, 08:50
Alfadil Haroon: Decoding the Complexity of Factor II Deficiency at EHA 2026
Alfadil Haroon, Assistant Consultant of Hematology at King Faisal Specialist Hospital and Research Centre, Assistant Professor at Alfaisal University, shared on LinkedIn:
”Decoding the complexity of factor II deficiency: new insights from EHA 2026
Factor II (prothrombin) deficiency is rare, but its clinical impact is profound. Our latest retrospective analysis of 106 patients reveals critical distinctions between congenital and acquired forms:
- Acquired FII Deficiency: Often presents later (median age 34) and is highly associated with autoimmune diseases and malignancy. Notably, 30.8% of these patients experience thrombotic events -strongly linked to autoimmune comorbidities (OR 5.43).
- Congenital FII Deficiency: Typically diagnosed much earlier (median age 16) with a significantly higher lifetime bleeding burden. Interestingly, we found no strong correlation between FII activity levels and bleeding severity, highlighting the need for individualized clinical assessment over lab values alone.
These findings underscore that Factor II deficiency isn’t just a bleeding disorder -it’s a complex balancing act between hemorrhage and thrombosis.”
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation